The present invention provides novel antibodies. In particular, the
present invention provides fusion antibodies comprising antibody heavy
and light chain fusions. The present invention further provides
multivalent antibodies comprising multiple fusion antibody chains. The
present invention further provides methods of generating splice resistant
antibody genes.